Geron Corp (GERN) option IV into FDA Oncologic Drugs Advisory Committee meeting

Geron Corp (NASDAQ: GERN) 30-day option implied volatility is at 265; compared to its 52-week range of 56 to 220 into FDA Oncologic Drugs Advisory Committee meeting.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1 call to 1 put into share price up before the bell
• Darden Restaurants (DRI) call put ratio 1.9 calls to 1 put as share price up 2.6% into the expected release of quarter results
• FedEx Freight (FDXF) call put ratio 2.7 calls to 1 put into quarter results